CN Stock MarketDetailed Quotes

301087 Cofoe Medical Technology

Watchlist
  • 39.65
  • -0.25-0.63%
Market Closed Nov 12 15:00 CST
8.29BMarket Cap31.37P/E (TTM)

Cofoe Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
5.87%2.25B
2.60%1.56B
-5.64%807.15M
-4.14%2.85B
13.11%2.12B
17.23%1.52B
42.38%855.37M
30.82%2.98B
10.60%1.88B
17.84%1.3B
Operating revenue
5.87%2.25B
2.60%1.56B
-5.64%807.15M
-4.14%2.85B
13.11%2.12B
17.23%1.52B
42.38%855.37M
30.82%2.98B
10.60%1.88B
17.84%1.3B
Other operating revenue
----
12.08%68.5M
----
37.00%148.02M
----
23.22%61.12M
----
-26.37%108.05M
----
-30.31%49.6M
Total operating cost
5.68%1.97B
3.76%1.34B
-0.02%676.81M
-1.96%2.59B
7.31%1.87B
10.27%1.29B
26.29%676.95M
44.43%2.65B
29.08%1.74B
37.18%1.17B
Operating cost
-5.79%1.09B
-6.19%768.79M
-3.05%404.95M
-10.11%1.62B
0.03%1.16B
2.93%819.48M
13.29%417.71M
40.87%1.8B
22.77%1.16B
31.18%796.12M
Operating tax surcharges
-12.00%19.24M
21.31%13.21M
11.88%6.9M
46.46%28.83M
104.84%21.87M
55.68%10.89M
101.57%6.17M
3.83%19.69M
-26.99%10.67M
-21.95%6.99M
Operating expense
35.49%711.66M
31.99%466.69M
11.55%218.53M
19.62%740.7M
20.98%525.23M
25.31%353.59M
57.12%195.9M
49.49%619.19M
43.19%434.16M
48.84%282.17M
Administration expense
4.17%95.7M
-1.62%61.17M
-8.71%29.52M
-8.78%110.92M
6.84%91.87M
11.79%62.18M
14.64%32.34M
113.85%121.6M
139.41%85.99M
147.18%55.62M
Financial expense
-37.71%-16.44M
-73.62%-12.91M
-16.89%-5.46M
42.74%-19.06M
45.06%-11.94M
48.74%-7.43M
52.03%-4.67M
-405.86%-33.29M
-873.38%-21.73M
-1,386.60%-14.5M
-Interest expense (Financial expense)
90.62%13.12M
-1.53%8.51M
3.10%2.72M
24.45%13.5M
-13.28%6.88M
30.99%8.64M
19.08%2.64M
59.38%10.85M
94.31%7.94M
158.19%6.59M
-Interest Income (Financial expense)
-35.89%-32.18M
-30.31%-22.07M
-6.35%-9.53M
25.25%-34.31M
33.72%-23.68M
22.87%-16.94M
37.77%-8.96M
-218.53%-45.89M
-1,495.33%-35.73M
-1,029.37%-21.96M
Research and development
-12.41%69.41M
-17.32%45.83M
-24.18%22.37M
-3.46%114.33M
12.77%79.24M
17.48%55.43M
39.82%29.5M
67.77%118.42M
52.55%70.27M
78.21%47.18M
Credit Impairment Loss
-179.07%-3.77M
-159.62%-2.69M
-145.78%-3.1M
94.43%-821.15K
222.24%4.77M
155.53%4.51M
78.01%-1.26M
-41.97%-14.75M
58.64%-3.9M
-97.79%-8.12M
Asset Impairment Loss
37.50%-31.68M
34.01%-26.47M
36.29%-21.44M
-12.69%-52.18M
-159.70%-50.68M
-141.72%-40.11M
-440.32%-33.66M
-159.53%-46.3M
-21.91%-19.52M
-51.95%-16.59M
Other net revenue
-20.19%18.96M
-112.42%-1.23M
46.94%-11.06M
-6.15%35.42M
-56.54%23.75M
-68.47%9.91M
-304.19%-20.85M
-44.22%37.74M
233.00%54.65M
84.68%31.42M
Fair value change income
-92.54%2.49M
-111.62%-2.55M
-25.28%7.54M
-135.50%-1.56M
-2.33%33.36M
-17.46%21.98M
749.05%10.09M
-30.47%4.4M
--34.16M
--26.63M
Invest income
1,485.88%15.04M
61,756.89%13.07M
-3,528.76%-431.7K
-15.92%47.72M
-45.93%948.55K
-102.28%-21.2K
-100.80%-11.9K
18,624.16%56.75M
995.00%1.75M
216.50%929.92K
-Including: Investment income associates
624.05%462.02K
-58.56%-101.77K
-3,528.76%-431.7K
-519.85%-130.24K
-212.02%-88.16K
-348.32%-64.19K
-165.20%-11.9K
93.14%-21.01K
85.58%-28.26K
103.24%25.85K
Asset deal income
-101.10%-53.86K
-96.27%89.9K
-30.74%63.21K
-29.07%4.59M
50.97%4.88M
317.30%2.41M
54.78%91.27K
4,546.87%6.47M
5,628.78%3.24M
5,364.12%578.14K
Other revenue
21.19%36.93M
-18.04%17.32M
61.76%6.31M
20.89%37.68M
-21.70%30.47M
-24.53%21.13M
-42.76%3.9M
-65.27%31.17M
-7.32%38.91M
-14.71%28M
Operating profit
4.92%294.75M
-8.64%214.6M
-24.30%119.28M
-20.00%294.73M
45.60%280.94M
52.85%234.9M
164.52%157.56M
-27.91%368.41M
-47.37%192.95M
-41.15%153.68M
Add:Non operating Income
2,038.69%4.21M
2,772.25%4.05M
377.61%488.9K
-13.00%381.6K
-40.90%196.91K
-33.76%141.04K
-27.63%102.36K
36.59%438.61K
-69.54%333.18K
35.92%212.92K
Less:Non operating expense
-17.11%4.01M
-33.65%2.52M
-51.77%1.02M
-72.71%9.4M
71.12%4.83M
67.96%3.79M
145.03%2.13M
1,039.20%34.46M
10.68%2.83M
174.54%2.26M
Total profit
6.75%294.96M
-6.54%216.14M
-23.66%118.74M
-14.56%285.71M
45.07%276.3M
52.51%231.25M
164.34%155.54M
-34.22%334.39M
-47.84%190.46M
-41.78%151.63M
Less:Income tax cost
26.81%43.02M
-0.27%31.43M
-20.14%17.7M
1.45%32.84M
58.63%33.92M
60.89%31.52M
257.08%22.17M
-58.89%32.37M
-64.61%21.39M
-55.82%19.59M
Net profit
3.94%251.94M
-7.52%184.7M
-24.24%101.04M
-16.27%252.87M
43.36%242.38M
51.26%199.73M
153.41%133.37M
-29.70%302.02M
-44.51%169.07M
-38.90%132.04M
Net profit from continuing operation
3.94%251.94M
-7.52%184.7M
-24.24%101.04M
-16.27%252.87M
43.36%242.38M
51.26%199.73M
153.41%133.37M
-29.70%302.02M
-44.51%169.07M
-38.90%132.04M
Less:Minority Profit
-94.94%21.3K
-133.26%-273.39K
83.99%-182.55K
-519.18%-1.41M
-73.48%420.61K
-54.52%821.96K
-146.98%-1.14M
-53.90%336.18K
450.16%1.59M
261.18%1.81M
Net profit of parent company owners
4.12%251.92M
-7.00%184.98M
-24.75%101.22M
-15.71%254.28M
44.47%241.96M
52.73%198.91M
167.93%134.51M
-29.65%301.68M
-44.98%167.48M
-39.60%130.24M
Earning per share
Basic earning per share
6.90%1.24
-4.21%0.91
-23.08%0.5
-14.48%1.24
45.00%1.16
53.23%0.95
170.83%0.65
-44.23%1.45
-58.97%0.8
-55.07%0.62
Diluted earning per share
6.03%1.23
-5.26%0.9
-24.62%0.49
-14.48%1.24
45.00%1.16
50.79%0.95
170.83%0.65
-44.23%1.45
-58.97%0.8
-54.35%0.63
Other composite income
Total composite income
3.94%251.94M
-7.52%184.7M
-24.24%101.04M
-16.27%252.87M
43.36%242.38M
51.26%199.73M
153.41%133.37M
-29.70%302.02M
-44.51%169.07M
-38.90%132.04M
Total composite income of parent company owners
4.12%251.92M
-7.00%184.98M
-24.75%101.22M
-15.71%254.28M
44.47%241.96M
52.73%198.91M
167.93%134.51M
-29.65%301.68M
-44.98%167.48M
-39.60%130.24M
Total composite income of minority owners
-94.94%21.3K
-133.26%-273.39K
83.99%-182.55K
-519.18%-1.41M
-73.48%420.61K
-54.52%821.96K
-146.98%-1.14M
-53.90%336.18K
450.16%1.59M
261.18%1.81M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 5.87%2.25B2.60%1.56B-5.64%807.15M-4.14%2.85B13.11%2.12B17.23%1.52B42.38%855.37M30.82%2.98B10.60%1.88B17.84%1.3B
Operating revenue 5.87%2.25B2.60%1.56B-5.64%807.15M-4.14%2.85B13.11%2.12B17.23%1.52B42.38%855.37M30.82%2.98B10.60%1.88B17.84%1.3B
Other operating revenue ----12.08%68.5M----37.00%148.02M----23.22%61.12M-----26.37%108.05M-----30.31%49.6M
Total operating cost 5.68%1.97B3.76%1.34B-0.02%676.81M-1.96%2.59B7.31%1.87B10.27%1.29B26.29%676.95M44.43%2.65B29.08%1.74B37.18%1.17B
Operating cost -5.79%1.09B-6.19%768.79M-3.05%404.95M-10.11%1.62B0.03%1.16B2.93%819.48M13.29%417.71M40.87%1.8B22.77%1.16B31.18%796.12M
Operating tax surcharges -12.00%19.24M21.31%13.21M11.88%6.9M46.46%28.83M104.84%21.87M55.68%10.89M101.57%6.17M3.83%19.69M-26.99%10.67M-21.95%6.99M
Operating expense 35.49%711.66M31.99%466.69M11.55%218.53M19.62%740.7M20.98%525.23M25.31%353.59M57.12%195.9M49.49%619.19M43.19%434.16M48.84%282.17M
Administration expense 4.17%95.7M-1.62%61.17M-8.71%29.52M-8.78%110.92M6.84%91.87M11.79%62.18M14.64%32.34M113.85%121.6M139.41%85.99M147.18%55.62M
Financial expense -37.71%-16.44M-73.62%-12.91M-16.89%-5.46M42.74%-19.06M45.06%-11.94M48.74%-7.43M52.03%-4.67M-405.86%-33.29M-873.38%-21.73M-1,386.60%-14.5M
-Interest expense (Financial expense) 90.62%13.12M-1.53%8.51M3.10%2.72M24.45%13.5M-13.28%6.88M30.99%8.64M19.08%2.64M59.38%10.85M94.31%7.94M158.19%6.59M
-Interest Income (Financial expense) -35.89%-32.18M-30.31%-22.07M-6.35%-9.53M25.25%-34.31M33.72%-23.68M22.87%-16.94M37.77%-8.96M-218.53%-45.89M-1,495.33%-35.73M-1,029.37%-21.96M
Research and development -12.41%69.41M-17.32%45.83M-24.18%22.37M-3.46%114.33M12.77%79.24M17.48%55.43M39.82%29.5M67.77%118.42M52.55%70.27M78.21%47.18M
Credit Impairment Loss -179.07%-3.77M-159.62%-2.69M-145.78%-3.1M94.43%-821.15K222.24%4.77M155.53%4.51M78.01%-1.26M-41.97%-14.75M58.64%-3.9M-97.79%-8.12M
Asset Impairment Loss 37.50%-31.68M34.01%-26.47M36.29%-21.44M-12.69%-52.18M-159.70%-50.68M-141.72%-40.11M-440.32%-33.66M-159.53%-46.3M-21.91%-19.52M-51.95%-16.59M
Other net revenue -20.19%18.96M-112.42%-1.23M46.94%-11.06M-6.15%35.42M-56.54%23.75M-68.47%9.91M-304.19%-20.85M-44.22%37.74M233.00%54.65M84.68%31.42M
Fair value change income -92.54%2.49M-111.62%-2.55M-25.28%7.54M-135.50%-1.56M-2.33%33.36M-17.46%21.98M749.05%10.09M-30.47%4.4M--34.16M--26.63M
Invest income 1,485.88%15.04M61,756.89%13.07M-3,528.76%-431.7K-15.92%47.72M-45.93%948.55K-102.28%-21.2K-100.80%-11.9K18,624.16%56.75M995.00%1.75M216.50%929.92K
-Including: Investment income associates 624.05%462.02K-58.56%-101.77K-3,528.76%-431.7K-519.85%-130.24K-212.02%-88.16K-348.32%-64.19K-165.20%-11.9K93.14%-21.01K85.58%-28.26K103.24%25.85K
Asset deal income -101.10%-53.86K-96.27%89.9K-30.74%63.21K-29.07%4.59M50.97%4.88M317.30%2.41M54.78%91.27K4,546.87%6.47M5,628.78%3.24M5,364.12%578.14K
Other revenue 21.19%36.93M-18.04%17.32M61.76%6.31M20.89%37.68M-21.70%30.47M-24.53%21.13M-42.76%3.9M-65.27%31.17M-7.32%38.91M-14.71%28M
Operating profit 4.92%294.75M-8.64%214.6M-24.30%119.28M-20.00%294.73M45.60%280.94M52.85%234.9M164.52%157.56M-27.91%368.41M-47.37%192.95M-41.15%153.68M
Add:Non operating Income 2,038.69%4.21M2,772.25%4.05M377.61%488.9K-13.00%381.6K-40.90%196.91K-33.76%141.04K-27.63%102.36K36.59%438.61K-69.54%333.18K35.92%212.92K
Less:Non operating expense -17.11%4.01M-33.65%2.52M-51.77%1.02M-72.71%9.4M71.12%4.83M67.96%3.79M145.03%2.13M1,039.20%34.46M10.68%2.83M174.54%2.26M
Total profit 6.75%294.96M-6.54%216.14M-23.66%118.74M-14.56%285.71M45.07%276.3M52.51%231.25M164.34%155.54M-34.22%334.39M-47.84%190.46M-41.78%151.63M
Less:Income tax cost 26.81%43.02M-0.27%31.43M-20.14%17.7M1.45%32.84M58.63%33.92M60.89%31.52M257.08%22.17M-58.89%32.37M-64.61%21.39M-55.82%19.59M
Net profit 3.94%251.94M-7.52%184.7M-24.24%101.04M-16.27%252.87M43.36%242.38M51.26%199.73M153.41%133.37M-29.70%302.02M-44.51%169.07M-38.90%132.04M
Net profit from continuing operation 3.94%251.94M-7.52%184.7M-24.24%101.04M-16.27%252.87M43.36%242.38M51.26%199.73M153.41%133.37M-29.70%302.02M-44.51%169.07M-38.90%132.04M
Less:Minority Profit -94.94%21.3K-133.26%-273.39K83.99%-182.55K-519.18%-1.41M-73.48%420.61K-54.52%821.96K-146.98%-1.14M-53.90%336.18K450.16%1.59M261.18%1.81M
Net profit of parent company owners 4.12%251.92M-7.00%184.98M-24.75%101.22M-15.71%254.28M44.47%241.96M52.73%198.91M167.93%134.51M-29.65%301.68M-44.98%167.48M-39.60%130.24M
Earning per share
Basic earning per share 6.90%1.24-4.21%0.91-23.08%0.5-14.48%1.2445.00%1.1653.23%0.95170.83%0.65-44.23%1.45-58.97%0.8-55.07%0.62
Diluted earning per share 6.03%1.23-5.26%0.9-24.62%0.49-14.48%1.2445.00%1.1650.79%0.95170.83%0.65-44.23%1.45-58.97%0.8-54.35%0.63
Other composite income
Total composite income 3.94%251.94M-7.52%184.7M-24.24%101.04M-16.27%252.87M43.36%242.38M51.26%199.73M153.41%133.37M-29.70%302.02M-44.51%169.07M-38.90%132.04M
Total composite income of parent company owners 4.12%251.92M-7.00%184.98M-24.75%101.22M-15.71%254.28M44.47%241.96M52.73%198.91M167.93%134.51M-29.65%301.68M-44.98%167.48M-39.60%130.24M
Total composite income of minority owners -94.94%21.3K-133.26%-273.39K83.99%-182.55K-519.18%-1.41M-73.48%420.61K-54.52%821.96K-146.98%-1.14M-53.90%336.18K450.16%1.59M261.18%1.81M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data